Literature DB >> 16923710

Gentamicin ototoxicity: clinical features and the effect on the human vestibulo-ocular reflex.

Gail Ishiyama1, Akira Ishiyama, Kevin Kerber, Robert W Baloh.   

Abstract

CONCLUSIONS: Gentamicin ototoxicity presents with gait imbalance and oscillopsia, but only rarely with hearing loss and vertigo. Sinusoidal rotational stimuli with high accelerations such as the bedside head-thrust test or rotational step changes in velocity are useful to diagnose bilateral vestibulopathy.
OBJECTIVE: To describe the salient clinical features and vestibular testing results in gentamicin ototoxicity. PATIENTS AND METHODS: A retrospective review of the quantitative vestibular function testing results for patients presenting to the UCLA Neurotology Clinic with gentamicin ototoxicity over the past 10 years (n=35).
RESULTS: All patients presented with imbalance and 33 out of 35 had oscillopsia. Three patients reported a noticeable change in hearing and five reported vertigo. Of the 35 patients, 15 were in renal failure at the time of gentamicin administration. Patients with pre-existing peripheral neuropathy compensated poorly. Sinusoidal rotational testing demonstrated profoundly decreased gain and increased phase lead over the entire frequency range, with a subset of patients having relatively preserved gain at the intermediate frequencies (0.8-1.6 Hz) and low acceleration (<30 degrees/s). There was little or no response to high acceleration step changes in velocity. The time constant measured both by sinusoidal and step responses was ultra-low. All patients tested had a positive head-thrust test bilaterally.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923710     DOI: 10.1080/00016480600606673

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  13 in total

1.  A distributed, dynamic, parallel computational model: the role of noise in velocity storage.

Authors:  Faisal Karmali; Daniel M Merfeld
Journal:  J Neurophysiol       Date:  2012-04-18       Impact factor: 2.714

2.  Aminoglycoside ototoxicity: Vestibular function is also vulnerable.

Authors:  Barry M Seemungal; Adolfo M Bronstein
Journal:  BMJ       Date:  2007-11-10

Review 3.  Video head impulse test: a review of the literature.

Authors:  Salman F Alhabib; Issam Saliba
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-06-21       Impact factor: 2.503

4.  Bayesian optimal adaptation explains age-related human sensorimotor changes.

Authors:  Faisal Karmali; Gregory T Whitman; Richard F Lewis
Journal:  J Neurophysiol       Date:  2017-11-08       Impact factor: 2.714

5.  Clinical Considerations for Routine Auditory and Vestibular Monitoring in Patients With Cystic Fibrosis.

Authors:  Angela C Garinis; Gayla L Poling; Ronald C Rubenstein; Dawn Konrad-Martin; Timothy E Hullar; David M Baguley; Holly L Burrows; Jennifer A Chisholm; Amy Custer; Laura Dreisbach Hawe; Lisa L Hunter; Theodore K Marras; Candice E Ortiz; Lucretia Petersen; Peter S Steyger; Kevin Winthrop; Erika M Zettner; Khaya Clark; Michelle Hungerford; Jay J Vachhani; Carmen C Brewer
Journal:  Am J Audiol       Date:  2021-09-22       Impact factor: 1.636

6.  Identification of a series of hair-cell MET channel blockers that protect against aminoglycoside-induced ototoxicity.

Authors:  Emma J Kenyon; Nerissa K Kirkwood; Siân R Kitcher; Richard J Goodyear; Marco Derudas; Daire M Cantillon; Sarah Baxendale; Antonio de la Vega de León; Virginia N Mahieu; Richard T Osgood; Charlotte Donald Wilson; James C Bull; Simon J Waddell; Tanya T Whitfield; Simon E Ward; Corné J Kros; Guy P Richardson
Journal:  JCI Insight       Date:  2021-04-08

Review 7.  A meta-analysis and systematic review of the prevalence of mitochondrially encoded 12S RNA in the general population: Is there a role for screening neonates requiring aminoglycosides?

Authors:  Titus S Ibekwe; Sanjiv K Bhimrao; Brian D Westerberg; Frederick K Kozak
Journal:  Afr J Paediatr Surg       Date:  2015 Apr-Jun

8.  Full Spectrum of Reported Symptoms of Bilateral Vestibulopathy Needs Further Investigation-A Systematic Review.

Authors:  Florence Lucieer; Stijn Duijn; Vincent Van Rompaey; Angelica Pérez Fornos; Nils Guinand; Jean Philippe Guyot; Herman Kingma; Raymond van de Berg
Journal:  Front Neurol       Date:  2018-06-04       Impact factor: 4.003

9.  Prevention of Severe Vestibular Hypofunction after Systemic Gentamicin.

Authors:  Sofía Ferreira-Cendon; Ramon Martinez-Carranza; Maria José Fernandez-Nava; Rosana Villaoslada-Fuente; Hortensia Sanchez-Gomez; Santiago Santa Cruz-Ruiz; María Sanchez-Ledesma; Angel Batuecas-Caletrio
Journal:  J Clin Med       Date:  2022-01-25       Impact factor: 4.241

10.  Bilateral Vestibular Hypofunction: Insights in Etiologies, Clinical Subtypes, and Diagnostics.

Authors:  F Lucieer; P Vonk; N Guinand; R Stokroos; H Kingma; Raymond van de Berg
Journal:  Front Neurol       Date:  2016-03-04       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.